Skip to main content
. 2022 Jun 22;10(7):992. doi: 10.3390/vaccines10070992

Figure 2.

Figure 2

The individual results of the Epstein–Barr virus (EBV) viremia during the follow-up period (The individual symbols mark the next patients and the dashed line marks the results of the patient who reactivated EBV infection).